Sotera Health (SHC) Income from Non-Controlling Interests (2020 - 2021)
Sotera Health (SHC) posted Income from Non-Controlling Interests of $326000.0 for Q2 2021, up 46.19% on a QoQ basis from $223000.0 in Q1 2021, and up 38.72% year-over-year from $235000.0 in Q2 2020.
Powered by 
Analysis
Sotera Health (SHC) Income from Non-Controlling Interests (2020 - 2021) Analysis & Trends
Sotera Health has reported Income from Non-Controlling Interests for 2 years, with the latest figure at $326000.0 in Q2 2021.
- On a quarterly basis, Income from Non-Controlling Interests rose 38.72% year-over-year to $326000.0 in Q2 2021; TTM through Mar 2022 was $326000.0, a 76.24% decrease from a year earlier, with the FY2021 full-year figure at $534000.0, down 52.58% from the prior year.
- Income from Non-Controlling Interests was $326000.0 for Q2 2021 at Sotera Health, up from $223000.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $620000.0 in Q3 2020, with the low at -$22000.0 in Q1 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | - |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 14.00 Mn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 400,000.00 |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | - |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | - |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | - |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | - |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | -153,000.00 |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | 326,000.00 |
| Mar 31, 2021 | 223,000.00 |
| Dec 31, 2020 | 294,000.00 |
| Sep 30, 2020 | 620,000.00 |
| Jun 30, 2020 | 235,000.00 |
| Mar 31, 2020 | -22,000.00 |